Weavercheek3960
© 2020 The Authors.Purpose We present a rare case of intramuscular alveolar soft part sarcoma (ASPS) of the lateral rectus (LR) muscle and the surgical technique used to maintain orthotropia after complete resection of the mass. Observations A 5-year-old boy presented with progressive proptosis of the left eye due to an orbital tumor. The patient was previously diagnosed with ASPS of the left LR muscle from an incisional biopsy, and the tumor size increased despite 5 cycles of chemotherapy prior to presenting to our center. Magnetic resonance imaging showed a 28x19x15mm-sized contrast-enhancing intramuscular mass of the left LR muscle, and there was no evidence of nodal or distant metastasis. The mass was excised en bloc, along with the insertion and the posterior normal part of LR muscle. To maintain proper eye alignment after resecting LR muscle, a 4-0 Prolene® hang-back suture was placed between the scleral insertion and the periorbita of the posterior orbit and the left medial rectus muscle was injected with botulinum toxin. During the follow-up of 51 months after surgery, the patient had no evidence of recurrence or metastasis and remained orthotropic in primary gaze, with a good cosmetic result. Conclusions and Importance ASPS of extraocular muscles is a rare tumor occurring mainly in children and young adults, and treatment may cause significant sequelae such as orbital exenteration, radiation-induced complications, and large-angle strabismus. Complete resection of tumor including the extraocular muscle is essential for treatment, and a subsequent reconstruction using a hang-back suture technique is useful to achieve proper eye alignment as well as a good cosmetic outcome. © 2020 The Authors.The physiological role of prolactin (PRL) in the heart, and in particular the diabetic heart, are largely unknown. The effects of PRL on ventricular myocyte shortening and Ca2+ transport in the streptozotocin (STZ) - induced diabetic and in age-matched control rats were investigated. PRL receptor protein, myocyte shortening, intracellular [Ca2+], L-type Ca2+ current were measured by Western blot, cell imaging, fluorescence photometry and whole-cell patch-clamp techniques, respectively. Compared to normal Tyrode solution (NT), PRL (50 ng/ml) significantly (p less then 0.05) increased the amplitude of shortening in myocytes from control (7.43 ± 0.38 vs. 9.68 ± 0.46 %) and diabetic (6.57 ± 0.24 vs. 8.91 ± 0.44 %) heart (n = 44-49 cells). Compared to NT, PRL (50 ng/ml) significantly increased the amplitude of Ca2+ transients in myocytes from control (0.084 ± 0.004 vs. 0.115 ± 0.007 Fura-2 ratio units) and diabetic (0.087 ± 0.007 vs. 0.112 ± 0.006 Fura-2 ratio units) heart (n = 36-50 cells). PRL did not significantly alter the amplitude of caffeine-evoked Ca2+ transients however, PRL significantly increased the fractional release of Ca2+ in myocytes from control (21 %) and diabetic (14 %) and heart. The rate of Ca2+ transient recovery following PRL treatment was significantly increased in myocytes from diabetic and control heart. Amplitude of L-type Ca2+ current was not significantly altered by diabetes or by PRL. PRL increased the amplitude of shortening and Ca2+ transients in myocytes from control and diabetic heart. Increased fractional release of sarcoplasmic reticulum Ca2+ may partly underlie the positive inotropic effects of PRL in ventricular myocytes from control and STZ-induced diabetic rat. © 2020 Published by Elsevier Ltd.Over the years, the inability of pharmaceutical companies to achieve optimum maintenance of their equipment, and enhanced machine availability for better resource and maintenance utilization, has adversely affected their competitive advantage. The need to adopt a unique production technique that will curb their numerous equipment maintenance challenges, and also re-position them for world-class manufacturing will not only reduce their losses, but will also increase their throughput and profitability. To address a Pharmaceutical firm's maintenance challenges, data were obtained for the Overall Equipment Effectiveness (OEE) factors after Total Productive Maintenance (TPM) implementation in the company. Minitab 16.0 software was used to analyze the data collected, and the results showed that the highest value of 98.90 and 96.39 in the descriptive statistics for the maximum and mean respectively, underscore the importance of quality in the company's products. The percentage of mean for quality, availability, and performance obtained were 96.3906, 60.4938, and 27.6188 respectively. This once again showed that quality of products is the greatest OEE factor that pharmaceutical companies must take seriously in order to reduce the six big losses in their manufacturing processes. Response Surface Method (RSM), with the application of Design Expert software with Box-Behnken as the design type was used to model, analyze, and optimize the Overall Equipment Effectiveness (OEE) using availability, quality, and performance as the input parameters. The analysis of both the actual and coded values, which is the main contribution of the study showed that quality has the greatest value followed by availability and performance. Also, OEE must be set at 10.3 and 629.5 for both the lower and upper limits respectively, in order to effectively reduce downtime, setup cost, the inherent wastes, as well as the six big losses. © 2020 The Author(s).Amoxicillin dispersible tablet (DT) is now recommended by the WHO as a first-line drug for the treatment of pneumonia in children below 5 years. The study aim was to compare acceptability, adherence and clinical outcome of amoxicillin DT and amoxicillin oral suspension (OS) in the treatment of children aged 2-59 months with pneumonia in Kenya. We conducted a two-arm cluster randomized controlled trial and utilized quantitative methods. The community unit was the unit of randomization. Children aged 2-59 months with pneumonia were enrolled and treated with either amoxicillin DT or OS. Gossypol nmr Acceptability was defined as the perception of taste of medication as the same or better compared to other medicines and expression of willingness of caregivers to use DT/OS in future, adherence was measured based on the dose, frequency, and duration of treatment, and clinical outcome as complete resolution of symptoms without change of antibiotic treatment. Equivalence was defined as a difference of ≤8% between study arms. We found high levels of acceptability among both DT (93.9%) and OS (96.1%) arms (difference 2.3%, 90% CI -2.6-7.3). The objective measure of adherence on day four and the overall objective measure were significantly higher among children on DT compared to children on OS (88.7% vs. 41.5% (difference 47.2%, 90% CI 31.0-63.3) & 83.5% vs. 39% (difference 44.5%, 90% CI 27.9-60.9), respectively). Cure rates were high in both arms (DT (99.5%), OS (98.1%), difference 1.4%, 90% CI -0.2-3.2). There is reported better adherence to Amoxicillin DT compared to OS and equivalence in acceptability and clinical outcomes. © 2020 The Author(s).In this study, we report the synthesis of the magnetite/silica nanocomposites and their structural and functional groups, magnetic properties, morphology, antimicrobial activity, and drug delivery performance. The X-ray diffraction characterization showed that magnetite formed a spinel phase and that silica formed an amorphous phase. The particle sizes of magnetite increased from 8.2 to 13.2 nm with increasing silica content, and the particles were observed to be superparamagnetic. The nanocomposites tended to agglomerate based on the scanning electron microscopy images. The antimicrobial activity of the magnetite/silica nanocomposites revealed that the increasing silica content increased the inhibition zones by 74%, 77%, and 143% in case of Gram-positive bacteria (B. subtilis), Gram-negative bacteria (E. coli), and fungus (C. albicans), respectively. Furthermore, doxorubicin was used as the model compound in the drug loading and release study, and drug loading was directly proportional to the silica content. Thus, the increasing silica content increased the drug loading owing to the increasing number of OH- bonds in silica, resulting in strong bonds with doxorubicin. Based on this study, the magnetite/silica nanocomposites could be applied as drug delivery vehicles. © 2020 The Author(s).The paper suggests a method for optimization of the process of integrated tests for complex technical equipment of automotive, aviation, and rocket systems based on an analysis of efficiency dynamics models. The method makes it possible to determine scopes of ground tests for complex technical equipment, which are minimally required to start field tests under the necessity to combine ground and field development. Exponential models of complex systems' development are used as efficiency dynamics models for the whole testing process as well as efficiency dynamics models at various levels of the hierarchy of tests. The paper addresses an optimization task when the structure of tests at each level of the hierarchy is specified, i.e. efficiency dynamics models are determined for each level. The authors determine optimal points of transition from one level of tests to another, considering the random nature of efficiency dynamics parameters. A method for optimization using determination of the optimal scope of field tests is given. © 2020 Published by Elsevier Ltd.1. As human-wildlife conflicts increase worldwide, novel methods are required for mitigating these conflicts. Fertility control, based on immunocontraceptives, has emerged as an alternative option to lethal methods for managing wildlife. 2. Immunocontraceptives are vaccines that generate an immune response to key components of an animal's reproductive system. Some of these vaccines target the gonadotropin-releasing hormone (GnRH) and have been used successfully as contraceptives for many wildlife species. However, the need to capture animals for treatment limits the field applications of injectable vaccines. The availability of orally delivered immunocontraceptives would increase the breadth of applications of fertility control for wildlife management. 3. This study explored a new approach to developing an oral immunocontraceptive, exploiting the bioadhesive and immunologically active properties of killed Mycobacterium avium cell wall fragments (MAF). The MAF was conjugated to a GnRH recombinant protein called IMX294, used as a GnRH-specific immunogen. 4. An initial trial using the MAF-IMX294 conjugate provided the first evidence that an orally delivered immunocontraceptive vaccine could generate anti-GnRH antibody titres in laboratory rats. 5. Increasing the dose and frequency of vaccine administered to rats, in a second trial, enhanced the immune response, eliciting titres that reduced the proportion of females giving birth. This provided the first evidence of the contraceptive effect of an oral anti-GnRH vaccine. 6. Future work is required to further increase the immunogenic effect of the oral vaccine and to establish a dosing schedule that is effective for practical field applications. © 2020 Published by Elsevier Ltd.The genetically engineered Chimeric Antigen Receptor bearing T-cell (CAR T cell) therapy has been emerged as the new paradigm of cancer immunotherapy. However, recent studies have reported an increase in the number of relapsed haematological malignancies. This review provides newer insights into how the efficacy of CAR T cells might be increased by the application of new genome editing technologies, monitoring the complexity of tumor types and T cells sub-types. Next, tumor mutation burden along with tumormicroenvironment and epigenetic mechanisms of CAR T cell as well as tumor cell may play a vital role to tackle the cancer resistance mechanisms. These studies highlight the need to consider traditional cancer therapy in conjunction with CAR T cell therapy for relapsed or cases unresponsive to treatment. Of note, this therapy is highly expensive and requires multi-skill for successful implementation, which results in reduction of its accessibility/affordability to the patients. Here, we also propose a model for cost minimization of CAR T cell therapy by a collaboration of academia, hospitals and industry.